0.5301
price down icon5.34%   -0.0299
after-market アフターアワーズ: .49 -0.0401 -7.56%
loading

Immunoprecise Antibodies Ltd (IPA) 最新ニュース

pulisher
11:39 AM

ImmunoPrecise Antibodies Ltd. (IPA) Launches AI-Powered Drug Discovery Pipeline, Revolutionizing Therapeutic Development with LENSai™ Platform - Yahoo Finance

11:39 AM
pulisher
09:38 AM

10 Trending AI Stocks on Latest News and Ratings - Insider Monkey

09:38 AM
pulisher
Jan 17, 2025

ImmunoPrecise launches AI-driven drug discovery pipeline - Investing.com India

Jan 17, 2025
pulisher
Jan 17, 2025

ImmunoPrecise Antibodies Launches AI-Powered Drug Discovery Platform - TipRanks

Jan 17, 2025
pulisher
Jan 17, 2025

ImmunoPrecise Launches Groundbreaking AI Platform LENSai for Revolutionary Drug Discovery - StockTitan

Jan 17, 2025
pulisher
Jan 17, 2025

Even With A 30% Surge, Cautious Investors Are Not Rewarding ImmunoPrecise Antibodies Ltd.'s (NASDAQ:IPA) Performance Completely - Simply Wall St

Jan 17, 2025
pulisher
Jan 04, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Stock Price Up 15.5% – What’s Next? - Defense World

Jan 04, 2025
pulisher
Jan 03, 2025

ImmunoPrecise Antibodies Announces CFO Resignation - TipRanks

Jan 03, 2025
pulisher
Jan 02, 2025

ImmunoPrecise Antibodies finance chief to step down - MSN

Jan 02, 2025
pulisher
Jan 02, 2025

ImmunoPrecise Antibodies announces resignation of CFO - Yahoo Finance

Jan 02, 2025
pulisher
Dec 31, 2024

ImmunoPrecise Antibodies Ltd. Announces the Resignation of Kristin Taylor as Chief Financial Officer, Effective January 16, 2025 - Marketscreener.com

Dec 31, 2024
pulisher
Dec 31, 2024

ImmunoPrecise Antibodies CFO Resignation and Succession - TipRanks

Dec 31, 2024
pulisher
Dec 31, 2024

ImmunoPrecise Antibodies CFO Kristin Taylor Announces Resignation, Will Transition Through January 2025 - StockTitan

Dec 31, 2024
pulisher
Dec 31, 2024

IPA Announces Resignation of Chief Financial Officer - Business Wire

Dec 31, 2024
pulisher
Dec 23, 2024

ImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share Purchases - The Globe and Mail

Dec 23, 2024
pulisher
Dec 23, 2024

ImmunoPrecise CEO Leads Major $306K Insider Stock Purchase, Signals Confidence in AI-Driven Strategy - StockTitan

Dec 23, 2024
pulisher
Dec 19, 2024

ImmunoPrecise Antibodies to Present at Microcap Conference 2025: AI-Driven Biotech Showcase - StockTitan

Dec 19, 2024
pulisher
Dec 19, 2024

ImmunoPrecise Antibodies to Showcase at Microcap Conference - TipRanks

Dec 19, 2024
pulisher
Dec 19, 2024

IPA to Present at The Microcap Conference 2025 - Business Wire

Dec 19, 2024
pulisher
Dec 14, 2024

HC Wainwright Has Optimistic Outlook of IPA Q3 Earnings - Defense World

Dec 14, 2024
pulisher
Dec 13, 2024

Research Analysts Set Expectations for IPA FY2028 Earnings - Defense World

Dec 13, 2024
pulisher
Dec 12, 2024

Immunoprecise shares target cut, retains buy rating on potential By Investing.com - Investing.com Nigeria

Dec 12, 2024
pulisher
Dec 12, 2024

Immunoprecise shares target cut, retains buy rating on potential - Investing.com

Dec 12, 2024
pulisher
Dec 11, 2024

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2025 Earnings Call Transcript - Insider Monkey

Dec 11, 2024
pulisher
Dec 11, 2024

ImmunoPrecise Antibodies Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Dec 11, 2024
pulisher
Dec 11, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q2 2025 Earnings Call Highlig - GuruFocus.com

Dec 11, 2024
pulisher
Dec 11, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q2 2025 Earnings Call Highlights: Strategic Moves and Growth ... - Yahoo Finance

Dec 11, 2024
pulisher
Dec 11, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q2 2025 Earnings Call Highlights: Strategic Moves and Growth ... By GuruFocus - Investing.com Canada

Dec 11, 2024
pulisher
Dec 10, 2024

ImmunoPrecise Antibodies Reports Mixed Financial Results - TipRanks

Dec 10, 2024
pulisher
Dec 10, 2024

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q2 Loss, Misses Revenue Estimates - MSN

Dec 10, 2024
pulisher
Dec 10, 2024

ImmunoPrecise Antibodies Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2024 - Marketscreener.com

Dec 10, 2024
pulisher
Dec 10, 2024

Immunoprecise Antibodies Ltd reports results for the quarter ended October 31Earnings Summary - XM

Dec 10, 2024
pulisher
Dec 10, 2024

ImmunoPrecise Antibodies Reports Q2 Results and Strategic Advances in AI-Driven Drug Discovery - TipRanks

Dec 10, 2024
pulisher
Dec 10, 2024

ImmunoPrecise Antibodies Expands with Strategic Growth in Biologics and CRO Services - TipRanks

Dec 10, 2024
pulisher
Dec 10, 2024

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025 - Business Wire

Dec 10, 2024
pulisher
Dec 10, 2024

ImmunoPrecise Antibodies Unveils Strategic BioNTech & Mayo Clinic Partnerships Amid Q2 Earnings Report - StockTitan

Dec 10, 2024
pulisher
Dec 04, 2024

IPA to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference - Business Wire

Dec 04, 2024
pulisher
Dec 03, 2024

IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025 on December 10, 2024 - The Globe and Mail

Dec 03, 2024
pulisher
Dec 03, 2024

ImmunoPrecise Antibodies to Announce Q1 Financial Results - TipRanks

Dec 03, 2024
pulisher
Nov 24, 2024

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Stock's 45% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St

Nov 24, 2024
pulisher
Nov 18, 2024

Immunoprecise Antibodies Ltd. Announces Resignation of Barry A. Springer from Board - Marketscreener.com

Nov 18, 2024
pulisher
Nov 13, 2024

ImmunoPrecise's Breakthrough Cancer Treatment Shows Promise in $20.7B ADC Market | IPA Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

$20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies - Business Wire

Nov 13, 2024
pulisher
Nov 06, 2024

ImmunoPrecise Antibodies (NASDAQ:IPA) Stock Price Down 2% – Here’s What Happened - Defense World

Nov 06, 2024
pulisher
Nov 05, 2024

ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation - BioSpace

Nov 05, 2024
pulisher
Oct 28, 2024

ImmunoPrecise Pummeled Despite Advancing Anti-Aging Research with Mayo - Baystreet.ca

Oct 28, 2024
pulisher
Oct 28, 2024

ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology - Business Wire

Oct 28, 2024
pulisher
Oct 24, 2024

ImmunoPrecise Antibodies Announces Annual Meeting Plans - TipRanks

Oct 24, 2024
pulisher
Oct 21, 2024

ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024 - BioSpace

Oct 21, 2024
pulisher
Oct 21, 2024

ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology - Pharmaceutical Technology

Oct 21, 2024
pulisher
Oct 21, 2024

ImmunoPrecise Antibodies to Join AI Drug Summit - TipRanks

Oct 21, 2024
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
大文字化:     |  ボリューム (24 時間):